Tech Sector. Updated key sells: None. Company Ticker Share price at Market Year end 22-Mar-17 cap FY17a/CY17e FY18e/CY18e FY17a/CY17e FY18e/CY18e

Size: px
Start display at page:

Download "Tech Sector. Updated key sells: None. Company Ticker Share price at Market Year end 22-Mar-17 cap FY17a/CY17e FY18e/CY18e FY17a/CY17e FY18e/CY18e"

Transcription

1 22 March 2017 Analyst Chris Savage Authorisation TS Lim Tech Sector Key picks unchanged: IRI, APX, ADA & IFM Stock Price Target Rating ADA $2.37 $3.25 Buy ALU $7.41 $7.90 Hold APX $2.58 $3.60 Buy CAT $2.15 $3.00 Buy (Spec) EPD $0.47 $0.70 Buy IFM $0.775 $0.90 Buy IRI $2.81 $3.50 Buy MLB $2.14 $2.75 Buy PSZ $0.325 $0.30 Hold SEN $0.091 $0.14 Buy SMP $0.20 $0.23 Buy TNE $4.91 $5.50 Hold WTC $5.65 $6.25 Buy Disclosure: Bell Potter Securities acted as comanager of WTC s IPO in April 2016 and received fees for that service. Key picks unchanged: IRI, APX, ADA & IFM We have updated our key picks in the tech sector post last month s reporting season but overall there is no change and our key picks remain the following: Integrated Research (IRI): CEO departure was a surprise but a strong 1HFY17 result and good momentum in the business keeps the stock as our number one pick in the sector; Appen (APX): Stronger than expected 2017 guidance of mid to high teens growth in EBITDA yet the stock has been sold off by >10% since the result and so now looks value on 2017 PE ratio of c.20x; Adacel Technologies (ADA): Relatively weak 1HFY17 result now in the past and outlook is for a record 2HFY17 result yet the stock has not bounced materially since the result and looks value on an FY17 PE ratio of c.18x ; and Infomedia (IFM): Better than expected 1HFY17 result and sales momentum continues to grow yet the stock still looks value on an FY17 PE ratio of c.20x. We last updated our key picks in December post the AGM season and made one change replacing Melbourne IT with Appen. Since then the Appen share price has fallen by around 5% (and the Melbourne IT share price has risen by around 10%!) while the share price of our three other key picks Integrated Research, Adacel Technologies and Infomedia have all risen modestly. Updated key sells: None We currently have no Sell recommendations in the sector. We have three Hold recommendations Altium, PS&C and Technology One but the share prices of all three stocks are either consistent with or below our price targets. Figure 1 - PE ratios and EV/EBITDA multiples for tech stocks under coverage Company Ticker Share price at Market Year end PE ratio EV/EBITDA 22-Mar-17 cap FY17a/CY17e FY18e/CY18e FY17a/CY17e FY18e/CY18e Adacel ADA $2.37 $187m Jun 18.4x 15.5x 12.8x 10.1x Altium ALU $7.41 $977m Jun 26.7x 20.6x 20.9x 16.5x Appen APX $2.58 $252m Dec 20.0x 17.4x 11.6x 9.8x Catapult Group Int'l CAT $2.15 $334m Jun NM >100x 86.2x 26.8x Empired EPD $0.47 $57m Jun 13.8x 8.3x 5.3x 4.0x Infomedia IFM $0.775 $232m Jun 20.1x 17.6x 8.6x 7.5x Integrated Research IRI $2.81 $461m Jun 26.1x 20.9x 12.1x 10.0x Melbourne IT MLB $2.14 $217m Dec 13.7x 10.5x 7.3x 6.6x PS&C PSZ $0.325 $21m Jun NM 4.9x 6.1x 5.7x Senetas SEN $0.091 $101m Jun 29.7x 16.6x 14.7x 10.5x Smartpay Holdings SMP $0.20 $33m Mar 16.9x 5.7x 6.1x 4.8x Technology One TNE $4.91 $1,570m Sep 32.7x 27.5x 22.8x 19.1x Wisetech Global WTC $5.65 $1,634m Jun 52.5x 38.0x 28.5x 20.5x SOURCE: BELL POTTER SECURITIES ESTIMATES BELL POTTER SECURITIES LIMITED ACN AFSL DISCLAIMER AND DISCLOSURES THIS REPORT MUST BE READ WITH THE DISCLAIMER AND DISCLOSURES ON PAGE 11 THAT FORM PART OF IT. Page 1

2 Contents Key Picks... 3 Company Summaries... 7 Page 2

3 Key Picks We have updated our key picks in the tech sector and these are detailed below. Integrated Research (BUY, PT $3.50) Integrated Research (IR) is a key pick for the following key reasons: Strong outlook: In our view the short to medium term outlook for IR is very good and we forecast strong EPS growth of between 15-25% in each of the next three years (FY17-FY19). The strong forecast growth in FY17 has already been set up by strong EPS growth in 1HFY17 of 24% while the strong forecast growth in FY18 and FY19 is due to an expected high level of renewals (particularly in FY18) as well as the rollout of the Cisco FedRamp contract. CEO departure does not change outlook: The departure of the CEO in February was a surprise to us but we do not believe it changes the outlook for the company. We did have high regard for the CEO but the strong momentum in the business means we did not see any need to change our forecasts when his departure was announced. We note the high calibre of some of the senior managers in IR (e.g. Andre Cuenin and Jason Barker) which gives us confidence the momentum in the business will continue. Protection against Avaya risk: IR has taken provisions against all of its net exposure to Avaya so there is no risk of a write-off if the customer does not pay off its receivable with the company. Rather, there is now upside risk if Avaya does successfully refinance its debt and pays off the amount owing over time. Note Avaya has continued to make payments to IR since it entered Chapter 11 earlier this year so IR appears to have taken a very conservative approach by providing against all of the net exposure. CEO appointment could be a catalyst: We expect the process of appointing a new CEO will take three to four months and so, in theory, a new CEO could be announced before 30 June. We see this as a potential catalyst for the stock given it will provide some clarity and certainty over who will take the company forward even though the momentum in the business means there is already a strong growth trajectory in place. Overall view: The sudden departure of the CEO offset the impact of a strong 1HFY17 result and the stock has traded sideways since the result. The appointment of a new CEO could therefore be the catalyst the stock needs given the earnings outlook is unchanged. Avaya emerging from Chapter 11 could also provide another catalyst even though the company has fully provided against its net exposure to the customer. Figure 2 - Financial summary for Integrated Research (@ $2.81 share price) Year end 30 June e 2018e 2019e Total revenue (A$m) EBITDA (A$m) NPAT (A$m) EPS (diluted) (cps) EPS grow th (%) 12% 15% 25% 19% PER (x) Price/CF (x) EV/EBITDA (x) Dividend ( ps) Yield (%) 2.3% 2.3% 3.2% 4.1% ROE (%) 39.1% 38.2% 39.4% 40.5% Franking (%) 58% 70% 75% 75% SOURCE: COMPANY DATA AND BELL POTTER SECURITIES ESTIMATES Page 3

4 Appen (BUY, PT $3.60) Appen is a key pick for the following key reasons: Strong guidance: Appen provided 2017 guidance of mid to high teens growth in EBITDA at the release of its 2016 result last month which was stronger that the 2016 guidance of low double digit earnings growth provided at the release of the 2015 result. The guidance was also stronger than we were expecting we thought Appen would start with low double digit again given the company is unlikely to have the benefit of much higher revenues from Facebook in 2017 as it did in This means the earnings growth in 2017 will likely come from a mix of revenue growth and margin expansion which is a better outcome that the earnings growth in 2016 which came from strong revenue growth but was offset by margin decline. Potential for guidance upgrade: Despite the better than expected 2017 guidance we still see potential for an upgrade to the guidance sometime around the AGM or 1H2017 result. In each of the last two years Appen has upgraded its guidance at or around the AGM and then also at the interim result and this has coincided with a successful renewal of contracts with key clients (e.g. Facebook and Microsoft) and an increasing order book. We see potential for the same to occur this year though, given the stronger than expected guidance at the start of the year, we would only expect one potential upgrade in Attractive value: In our view Appen deserves to trade on a PE ratio between 20-25x and at present the stock is trading at the bottom end of that range based on our 2017 forecasts. The obvious potential catalyst to drive a re-rating of the PE ratio towards the higher end of the range is an upgrade to the guidance which we believe may occur sometime around mid year. Potential for M&A: Appen had cash of $16.5m at 31 December 2016 and no debt. The company made its first acquisition as a listed company in 2016 when it acquired Mendip Media Group for c.$2.5m. We expect Appen to make more acquisitions going forward and, following a successful first acquisition, we expect some of these to be larger and potentially much larger in size. We also expect any acquisition to be EPS accretive given the ability to partly or wholly fund the acquisition out of cash and/or debt as well as the reasonable multiple of Appen s shares. Overall view: Despite the positive outlook for 2017 the Appen share price has fallen around 10% since the result and in our view the fall is unwarranted given the better than expected guidance. The obvious potential catalyst for the stock is an upgrade to the 2017 guidance which we believe may come around the AGM or at the 1H2017 result. Figure 3 - Financial summary for Appen (@ $2.58 share price) Year end 31 December e 2018e 2019e Total revenue (A$m) EBITDA (A$m) NPAT (A$m) EPS (diluted) (cps) EPS grow th (%) 23% 23% 15% 12% PER (x) Price/CF (x) EV/EBITDA (x) Dividend ( ps) Yield (%) 1.9% 2.3% 2.7% 3.1% ROE (%) 29.6% 28.4% 26.5% 24.7% Franking (%) 100.0% 100.0% 100.0% 100.0% SOURCE: COMPANY DATA AND BELL POTTER SECURITIES ESTIMATES Page 4

5 Adacel Technologies (BUY, PT $3.25) Adacel Technologies (Adacel) is a key pick for the following key reasons: Share price fall looks overdone: The Adacel share price has fallen by >30% over the past several months and the key driver of this fall appears to have been a relatively weak 1HFY17 result which was driven by a fall in Systems sales relative to the pcp. The outlook now, however, is for a rebound in Systems sales and a relatively strong 2HFY17 result which, according to the company s guidance, will help drive growth in pre-tax profit of 10% or more for the full year. The large fall in the share price does not, therefore, seem consistent with the year-on-year double digit profit growth in FY17. Recurring services revenue now 60-65% of total: We do recognise that the lumpiness in Systems sales is of some concern and can cause earnings volatility between results. But we also highlight that Systems sales are now only between 35-40% of total sales and the remaining 60-65% is Services revenue which is recurring and is expected to grow. We do therefore expect the lumpiness in Systems sales to become less of an issue going forward and for there to be less earnings volatility between results. Attractive value: The fall in the share price has reduced the FY17 PE ratio from c.25x to c.18x based on our forecasts which are modestly ahead of the guidance. In our view this is an attractive PE ratio for a global software company with a leading market position and a relatively high level of recurring revenue. Potential catalysts: We see some potential catalysts for Adacel over the next few months including contract wins (e.g. French Territories and US Navy) and a reiteration of the guidance. Note we do not believe the French Territories and/or US Navy contracts are necessary to achieve the guidance thought winning one or both would make it easier to achieve and potentially exceed. Potential capital management: Adacel had cash of c.$15m at 31 December 2016 and the company has no debt. Adacel has indicated it would like to make acquisitions if it is able to find suitable companies with complementary software and/or services at a reasonable price but has also indicated that, in the absence of any acquisitions, it will consider various capital management initiatives. Overall view: The fall in the share price looks overdone given the guidance of double digit growth for the full year but there appears to be some doubt in the market this will be achieved following the relatively weak 1HFY17 result. The reiteration of the FY17 guidance towards financial year end is therefore a key potential catalyst for the stock which may coincide with contract wins which could also serve as catalysts. Figure 4 - Financial summary for Adacel Technologies (@ $2.37 share price) Year end 30 June e 2018e 2019e Total revenue (A$m) EBITDA (A$m) NPAT (A$m) EPS (diluted) (cps) EPS grow th (%) 135% 11% 18% 11% PER (x) Price/CF (x) EV/EBITDA (x) Dividend ( ps) Yield (%) 1.3% 1.9% 2.6% 3.4% ROE (%) 45.5% 35.5% 31.7% 28.0% Franking (%) 0% 0% 0% 0% SOURCE: COMPANY DATA AND BELL POTTER SECURITIES ESTIMATES Page 5

6 Infomedia (BUY, PT $0.90) Infomedia is a key pick for the following key reasons: Turnaround continues: Infomedia has now won two key contracts Nissan Global and Nissan Europe since the loss of the JLR contract early last calendar year. This suggests the loss of the JLR contract was an anomaly and is unlikely to be repeated. The two new contracts offset the financial impact of the loss of the JLR contract particularly the EPC contract with Nissan globally albeit there is a timing difference of around a year. Pipeline remains strong: Infomedia said in its 1HFY17 result presentation that there is a solid pipeline in all products and regions and it also expected the contract sales momentum to continue. We therefore expect more contract wins going forward though these may not necessarily be of a size that warrant an ASX announcement. But we expect these contract wins to help drive top and bottom line growth over the medium term and supplement the large contract rollouts with Nissan globally and in Europe. Attractive value: The Infomedia share price rallied up to around $0.80 on the back of a better than expected 1HFY17 result but has subsequently dropped back to around $0.75. We believe the stock represents value at current levels given the FY17 PE ratio is back around 20x and drops to around 17x based on our FY18 forecasts. Note our FY17 forecasts are consistent with the guidance. Timing difference may provide opportunity: The only caveat on our key pick rating of Infomedia is that, as mentioned, there is a timing difference of about a year between the roll off of the JLR contract and the rollout of the Nissan Global contract. This timing difference will be most evident in the 1HFY18 result when the former is gathering pace and nearing its completion while the latter is only in its infancy. This will likely cause some weakness in the 1HFY18 result relative to 1HFY17 and we expect growth to only be modest at best. This may cause some weakness in the share price but we would view this as an opportunity given we expect the growth to be much better in 2HFY18 as the contract rollout for Nissan Global gathers steam. Overall view: Looks value again on an FY17 PE ratio of c.20x with the recent pullback in the share price after the rally which occurred on the back of a better than expected 1HFY17 result. Our confidence in the medium term outlook has increased with the winning of the Nissan Global contract which effectively offsets the loss of the JLR contract and the likelihood of more contract wins to come given the solid pipeline. Potential for some weakness in 1HFY18 result is the only area of concern but this is more due to a timing difference so does not change our view on the outlook for the company. Figure 5 - Financial summary for Infomedia (@ $0.775 share price) Year end 30 June e 2018e 2019e Total revenue (A$m) EBITDA (A$m) NPAT (A$m) EPS (diluted) (cps) EPS grow th (%) -23% 16% 14% 17% PER (x) Price/CF (x) EV/EBITDA (x) Dividend ( ps) Yield (%) 3.4% 3.8% 4.2% 4.8% ROE (%) 23.4% 24.8% 25.8% 27.3% Franking (%) 38% 100% 100% 100% SOURCE: COMPANY DATA AND BELL POTTER SECURITIES ESTIMATES Page 6

7 Company Summaries Integrated Research (IRI) Company Description Integrated Research (IR) is a leading global provider of performance management software for business-critical computing environments. The core product of the company Prognosis is an integrated suite of products that provides availability and performance management, diagnostics and insight for systems including Unified Communications, Payments and IT Infrastructure. Prognosis is used by many of the world s largest organisations including major stock exchanges, banks and telecommunication companies. Investment Thesis We maintain our BUY recommendation on IR. Our investment thesis is based on: Valuation: Our 12 month price target for IR is $3.50. The PT is generated from a blend of three valuation methodologies we apply to the company: PE ratio, EV/EBITDA and DCF. The price target is a 25% premium to the current share price and the total expected return (which includes the forecast dividend yield) is 27%. High level of recurring revenue: IR generates most of its revenue through licence and maintenance fees which combined represent >90% total revenue. The maintenance fees (c.31% of total revenue) are by nature highly recurring but the licence fees (c.55% of total revenue) are also highly recurring as the licences are typically sold on a fixed term and the company has a very high renewal rate (>95%). Tier one global customers: IR is a truly global company (>95% of total revenue is generated outside of Australia) and has a tier one customer base including many of the world s largest organisations. Companies that use IR s software include ten of the top ten US banks, six of the top ten automotive companies, six of the ten biggest telcos, and six of the top ten financial services companies globally. Key Risks Key downside risks to our estimates and valuation include (but are not limited to): Technology risk: IR is a technology company that designs, develops and distributes software. The risk with any such company is that the software does not perform to the clients expectations or is flawed in some way. Such an occurrence would negatively impact the company s reputation and provide downside risk to our estimates. Competition risk: IR operates in a competitive market and there is the risk of aggressive or irrational behaviour from one or more competitors who could force down prices and reduce operating margins across the entire market. Key product risk: IR has one key product Prognosis and so has key product risk if demand or the outlook for that product changes or, worse, the product becomes superseded or obsolete. IR aims to mitigate this risk by regularly updating the product and adding new functionality and features to the software (e.g. mobile access and interface, cloud-based delivery, etc.) as well as developing various versions for different platforms, vendors and applications. Page 7

8 Appen (APX) Company Description Appen Ltd (Appen) is a leading global provider of language technology data and services to enterprise and government customers. The company has a unique combination of proprietary technology, experienced management and an extensive network of native language evaluators. The company has two operating divisions: Content Relevance: Provides smart data to increase online discovery and search relevance of global search engines and e-commerce and social media platforms; and Language Resources: Provides training data for speech-recognition technologies in devices such as mobile phones, computer games and TV consoles. Appen was established in 1996 and has a long track record of revenue growth and strong margins. The company currently has circa 280 staff across offices in Australia, the US, the UK, China and the Philippines. Investment Thesis We maintain our BUY recommendation on Appen. Our investment thesis is based on: Valuation: Our 12 month price target on Appen is $3.60. The PT is generated from a blend of three valuation methodologies we apply to the company: PE ratio, EV/EBITDA and DCF. The price target is a 40% premium to the current share price and the total expected return (which includes the forecast dividend yield) is 42%. Long track record: Appen was established in 1996 and has a long track record of revenue growth and strong margins. In 2016 the company recorded revenue and EBITDA growth of 34% and 24% respectively. Strong customer relationships: The key competitive advantage of Appen is the longstanding relationships it has with many of its customers. For instance, Appen has been working with Microsoft Research for over 21 consecutive years. Further, the majority of revenue is from repeat customers as they update and upgrade their products. Key Risks Key downside risks to our estimates and valuation include (but are not limited to): Concentration of customer base: The customer base of Appen is relatively concentrated with the largest five clients representing c.73% of 2015 revenue. The loss of any one of these large clients or a meaningful shortfall in the forecast level of revenue from one or more would negatively impact the financial performance of the company. Unpredictability of revenue model: Appen generates most of its revenue from individual projects rather than long term contracts. The award of these projects can be lumpy and unpredictable and there is also no guarantee a customer will re-engage with Appen on future projects. Level of competition: Appen competes in the global Language Services industry which is competitive but fragmented with around 18,000 service providers. An increase in the level of competition through consolidation or vertical integration could negatively impact the financial performance of the company. Page 8

9 Adacel Technologies (ADA) Company Description Adacel Technologies (Adacel) is a leading global provider of simulation and control systems for the civil aviation and defence sectors. The core products of the company are air traffic control (ATC) simulation systems (where it is the leading global provider) and air traffic management (ATM) automation systems (where it is more of a niche provider). Adacel has also developed speech recognition technology which it uses in its ATC simulation systems as well as other products. Investment Thesis We maintain our BUY recommendation on Adacel. Our investment thesis is based on: Valuation: Our 12 month price target on Adacel is $3.25. The PT is generated from a blend of three valuation methodologies we apply to the company: PE ratio, EV/EBITDA and DCF. The price target is a 37% premium to the current share price and the total expected return (which includes the forecast dividend yield) is 39%. Diversified with a high level of recurring revenue: Adacel has undergone a significant transformation over the past five years and today is a much more diversified company with less volatility in earnings and improved visibility. The company generates revenue from two key areas systems and services where the latter is recurring and underpinned by long term contracts. The current split between systems and services (i.e. non-recurring and recurring) is approximately 35%/65%. High barriers to entry: Adacel has a large installed base of both ATC simulation and ATM automation systems and, once installed, these systems tend to be in service for years or more. Over this time the systems need maintenance and upgrades and, because Adacel owns the source code behind the systems, it is the only one that can provide these services. The large installed base of systems is therefore a barrier to entry for new entrants and also provides Adacel with long term recurring revenue. Key Risks Key downside risks to our estimates and valuation include (but are not limited to): Lumpiness in revenue: Adacel generates around 35% of its revenue from systems sales which are non-recurring and can cause lumpiness in revenue. Adacel has attempted to reduce the lumpiness of revenue in the business by increasing the level of recurring services revenue but systems sales will always remain a key part of the business and so there will always be some level of non-recurring revenue. Customer concentration risk: Adacel generates more than 50% of its revenue from three key customers: FAA, the US Department of Defence and Leidos. All three have been long term customers of Adacel (i.e. >10 years) and all have recently signed new long term contracts with the company. There is still risk, however, given the contracts tend to have multiple one-year options and the customers or contracts are government funded and so there is risk of cuts or volatility in funding levels. Key product risk: Adacel has two key products ATC simulation systems and ATM automation systems and most of its services revenue is derived from the sale and support of these two products. There is risk, therefore, if the demand or outlook for one or both of these products changes. Page 9

10 Infomedia (IFM) Company Description Infomedia is a leading provider of software solutions to the parts and service sector of the global automotive industry. The key products of the company are online parts selling systems and sophisticated service selling systems. The company also provides data analysis and information research for the automotive and lubricant industries. Investment Thesis We maintain our BUY recommendation on Infomedia. Our investment thesis is based on: $0.90 price target: Our 12 month price target on Infomedia is $0.90. The PT is generated from a blend of three valuation methodologies we apply to the company: PE ratio, EV/EBITDA and DCF. The price target is a 16% premium to the current share price and the total expected return (which includes the forecast dividend yield) is 20%. One mature product, one immature product: Infomedia has one mature product Microcat which is used by a large number of customers and generates approximately 75% of the company s revenue. Infomedia also has one immature product Superservice which is gaining traction in a fragmented market and generates approximately 20% of the company s revenue. The outlook is for continued modest growth in the mature product and potentially strong growth in the immature product. High level of recurring revenue: All of Infomedia s products are sold on a subscription basis so almost all of the revenue is recurring. Infomedia is currently in the process of moving towards reporting monthly recurring revenue but has yet to disclose what the amount is. We estimate that around 95% of total revenue is recurring and this easily exceeds the cost base of the company. Key Risks Key downside risks to our estimates and valuation include (but are not limited to): Loss of key licence agreements: Continued access to OEM parts information is integral to several of Infomedia s product lines. Loss of this access through the loss of one or more key licence agreements would therefore have an adverse impact on one or more of the company s product lines and negatively impact the financial performance. Infomedia attempts to mitigate this risk by managing key account relationships, continually investing in its products and focusing on customer service. Loss of key customers: The relatively concentrated motor manufacturing industry means there is a degree of customer and revenue concentration for Infomedia. The loss of a key customer, therefore, would have an adverse impact on the company s revenue and negatively impact the financial performance. Infomedia attempts to mitigate this risk by, again, managing key account relationships, focusing on identification of new OEM licence agreements and participating in industry forums. Product obsolescence or substitution: Infomedia operates in a competitive market and a risk is that its products do not keep up with developments in market needs or competitors (including OEMs) may develop superior products. Either outcome would have an adverse impact on demand for the company s products and negatively impact the financial performance. Infomedia attempts to mitigate this risk by closely monitoring market developments, direction and OEM strategies and continually investing in R&D. Page 10

11 Recommendation structure Buy: Expect >15% total return on a 12 month view. For stocks regarded as Speculative a return of >30% is expected. Research Team Staff Member TS Lim Sam Haddad Jonathon Higgins Title/Sector Head of Research Phone tslim shaddad jhiggins Hold: Expect total return between -5% Chris Savage csavage and 15% on a 12 month view Jonathan Snape jsnape Sell: Expect <-5% total return on a 12 month view Tim Piper John Hester Tanushree Jain Healthcare Healthcare/Biotech tpiper jhester tnjain Speculative Investments are either start-up enterprises with nil or only prospective operations or recently commenced operations with only forecast cash flows, or companies that have commenced operations or have been in operation for some time but have only forecast cash flows and/or a stressed balance sheet. Financials TS Lim Lafitani Sotiriou Resources Peter Arden David Coates Quantitative James Filius Banks/Regionals Diversified Resources Resources Associate Analyst tslim lsotiriou parden dcoates jfilius Such investments may carry an exceptionally high level of capital risk and volatility of returns. Bell Potter Securities Limited ACN Level 38, Aurora Place 88 Phillip Street, Sydney 2000 Telephone The following may affect your legal rights. Important Disclaimer: This document is a private communication to clients and is not intended for public circulation or for the use of any third party, without the prior approval of Bell Potter Securities Limited. In the USA and the UK this research is only for institutional investors. It is not for release, publication or distribution in whole or in part to any persons in the two specified countries. In Hong Kong this research is being distributed by Bell Potter Securities (HK) Limited which is licensed and regulated by the Securities and Futures Commission, Hong Kong. This is general investment advice only and does not constitute personal advice to any person. Because this document has been prepared without consideration of any specific client s financial situation, particular needs and investment objectives ( relevant personal circumstances ), a Bell Potter Securities Limited investment adviser (or the financial services licensee, or the representative of such licensee, who has provided you with this report by arraignment with Bell Potter Securities Limited) should be made aware of your relevant personal circumstances and consulted before any investment decision is made on the basis of this document. While this document is based on information from sources which are considered reliable, Bell Potter Securities Limited has not verified independently the information contained in the document and Bell Potter Securities Limited and its directors, employees and consultants do not represent, warrant or guarantee, expressly or impliedly, that the information contained in this document is complete or accurate. Nor does Bell Potter Securities Limited accept any responsibility for updating any advice, views opinions, or recommendations contained in this document or for correcting any error or omission which may become apparent after the document has been issued. Except insofar as liability under any statute cannot be excluded. Bell Potter Limited and its directors, employees and consultants do not accept any liability (whether arising in contract, in tort or negligence or otherwise) for any error or omission in this document or for any resulting loss or damage (whether direct, indirect, consequential or otherwise) suffered by the recipient of this document or any other person. Disclosure of interest: Bell Potter Securities Limited, its employees, consultants and its associates within the meaning of Chapter 7 of the Corporations Law may receive commissions, underwriting and management fees from transactions involving securities referred to in this document (which its representatives may directly share) and may from time to time hold interests in the securities referred to in this document. Bell Potter Securities acted as co-manager of WTC s IPO in April 2016 and received fees for that service. ANALYST CERTIFICATION Each research analyst primarily responsible for the content of this research report, in whole or in part, certifies that with respect to each security or issuer that the analyst covered in this report: (1) all of the views expressed accurately reflect his or her personal views about those securities or issuers and were prepared in an independent manner and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by that research analyst in the research report. Page 11

Adacel Technologies (ADA)

Adacel Technologies (ADA) 9 November 2018 Chris Savage 612 8224 2835 Authorisation TS Lim 612 8224 2810 Adacel Technologies (ADA) Bad, but not that bad Recommendation Buy (unchanged) Price $0.88 Target (12 months) $1.50 (previously

More information

Platinum Asset Management (PTM)

Platinum Asset Management (PTM) 24 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Recommendation Hold (unchanged) Price $5.10 Target (12 months) $4.90

More information

Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions

Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions 16 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation TS Lim 612 8224 2810 Perpetual (PPT) Oversold, upgrade to Buy Recommendation Buy (Hold) Price $42.09 Target (12 months) $47.50 (previously

More information

OneVue Holdings (OVH)

OneVue Holdings (OVH) 7 August 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 OneVue Holdings (OVH) FY17 result to show cost-out progress Recommendation

More information

OneVue Holdings (OVH)

OneVue Holdings (OVH) 24 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation Peter Arden 613 9235 1833 OneVue Holdings (OVH) Restructured and focused Recommendation Buy (unchanged) Price $0.745 Target (12 months)

More information

BWX Limited (BWX) SOURCE: BELL POTTER SECURITIES ESTIMATES

BWX Limited (BWX) SOURCE: BELL POTTER SECURITIES ESTIMATES 9 February 2017 Analyst John O'Shea 613 9235 1633 Authorisation John Hester 612 8224 2871 Recommendation Buy (unchanged) Price $4.80 Target (12 months) $5.73 (unchanged) Expected Return Capital growth

More information

Nanosonics (NAN) Preparing for new international markets. Maintain Hold, price target amended to $3.20 SOURCE: BELL POTTER SECURITIES ESTIMATES

Nanosonics (NAN) Preparing for new international markets. Maintain Hold, price target amended to $3.20 SOURCE: BELL POTTER SECURITIES ESTIMATES 21 February 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Nanosonics (NAN) Growth Slowly Emerging In Europe Recommendation Hold (unchanged) Price $2.80 Target (12 months) $3.20

More information

Mayne Pharma (MYX) Yet Another Transformational Acquisition. FY16 Earnings Confirmed. The company did not provide guidance in respect of FY17.

Mayne Pharma (MYX) Yet Another Transformational Acquisition. FY16 Earnings Confirmed. The company did not provide guidance in respect of FY17. 29 June 2016 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Mayne Pharma (MYX) Merger Fallout Creates Opportunity Recommendation Buy (unchanged) Price $1.485 Target (12 months) $1.89

More information

Challenger (CGF) Expanding the potential. A broader and more robust business emerging. Earnings revisions SOURCE: BELL POTTER SECURITIES ESTIMATES

Challenger (CGF) Expanding the potential. A broader and more robust business emerging. Earnings revisions SOURCE: BELL POTTER SECURITIES ESTIMATES 14 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Challenger (CGF) Expanding the potential Recommendation Buy (unchanged)

More information

Nanosonics (NAN) Summary of 2Q17 Cash Flows SOURCE: BELL POTTER SECURITIES ESTIMATES

Nanosonics (NAN) Summary of 2Q17 Cash Flows SOURCE: BELL POTTER SECURITIES ESTIMATES 16 January 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Nanosonics (NAN) US Market Continues To Expand Recommendation Hold (unchanged) Price $3.16 Target (12 months) $3.28

More information

Osprey (OSP) FY16 EBITDA Loss In Line. OSP has US$21.8m of cash as at 31 December Maintain Buy Rating And Valuation at $0.55

Osprey (OSP) FY16 EBITDA Loss In Line. OSP has US$21.8m of cash as at 31 December Maintain Buy Rating And Valuation at $0.55 27 February 2017 Analyst John Hester 612 8224 2871 Authorisation Tanushree Jain 612 8224 2849 Recommendation Buy (unchanged) Price $0.415 Valuation $0.55 (unchanged) Risk Speculative GICS Sector Healthcare

More information

Fortescue Metals Group Ltd (FMG)

Fortescue Metals Group Ltd (FMG) 3 March 2017 Analyst David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Fortescue Metals Group Ltd (FMG) All about the iron ore price Recommendation Sell (unchanged) Price $6.62 Target

More information

ANZ Bank (ANZ) Unquestionably strong 1Q17. Healthy Jaws, safe to go back in the water SOURCE: BELL POTTER SECURITIES ESTIMATES

ANZ Bank (ANZ) Unquestionably strong 1Q17. Healthy Jaws, safe to go back in the water SOURCE: BELL POTTER SECURITIES ESTIMATES 17 February 2017 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 ANZ Bank (ANZ) Unquestionably strong 1Q17 Recommendation Buy (Hold) Price $30.21 Target (12 months) $33.25 (previously

More information

IPH Limited (IPH) Buy at the bottom

IPH Limited (IPH) Buy at the bottom 29 March 2017 Analyst Sam Haddad 612 8224 2819 Authorisation TS Lim 612 8224 2810 IPH Limited (IPH) Buy at the bottom Recommendation Buy (unchanged) Price $4.76 Target (12 months) $7.90 (unchanged) Expected

More information

SurfStitch (SRF) Shaping the Surf industry. Acquisition in Product drives credibility. however we have some concerns

SurfStitch (SRF) Shaping the Surf industry. Acquisition in Product drives credibility. however we have some concerns 26 November 20 Analyst Sam Byrnes 612 8224 2886 Authorisation Chris Savage 612 8224 2835 SurfStitch (SRF) Shaping the Surf industry Recommendation Buy (unchanged) Price $2.06 Target (12 months) $2.65 (previously

More information

Auswide Bank (ABA) There are no tricks in plain and simple faith. 24 August : Underlying NPAT $17m, final dividend 18cps

Auswide Bank (ABA) There are no tricks in plain and simple faith. 24 August : Underlying NPAT $17m, final dividend 18cps 24 August 2018 TS Lim 612 8224 2810 Authorisation Tim Piper 612 8224 2825 Recommendation Buy (unchanged) Price $5.71 Target (12 months) $6.20 (previously $5.80) GICS Sector Banks Expected Return Capital

More information

Cyclopharm (CYC) Entry to US market inching closer. Maintain Buy Recommendation SOURCE: BELL POTTER SECURITIES ESTIMATES

Cyclopharm (CYC) Entry to US market inching closer. Maintain Buy Recommendation SOURCE: BELL POTTER SECURITIES ESTIMATES Analyst John Hester 612 8224 2871 Cyclopharm (CYC) 5 March 2018 Speculative See key risks on Page 4 and Biotechnology Risk Warning on Page 7. Speculative securities may not be suitable for Retail Clients.

More information

ANZ Banking Group (ANZ)

ANZ Banking Group (ANZ) 1 May 2018 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $27.47 Target (12 months) $30.20 (unchanged) GICS Sector Banks Expected Return Capital

More information

Aeon Metals Limited (AML)

Aeon Metals Limited (AML) Analyst David Coates 612 8224 2887 Authorisation Stuart Howe 613 9235 1856 Speculative See key risks on Page 4 Speculative securities may not be suitable for retail clients 22 March 2019 Aeon Metals Limited

More information

National Australia Bank (NAB)

National Australia Bank (NAB) 6 February 2017 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $30.39 Target (12 months) $32.50 (previously $30.00) Expected Return Capital growth

More information

Premier Investments (PMV)

Premier Investments (PMV) 16 March 2018 Analyst Sam Haddad 612 8224 2819 Authorisation Tim Piper 612 8224 2825 Premier Investments (PMV) Key growth pillars all strong Recommendation Buy (unchanged) Price $15.27 Target (12 months)

More information

Westgold Resources (WGX)

Westgold Resources (WGX) 3 September 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $1.36 Target (12 months) $2.15 (unchanged) Expected Return Capital growth

More information

Commonwealth Bank (CBA)

Commonwealth Bank (CBA) 10 February 2016 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Commonwealth Bank (CBA) Ordeal and triumph Recommendation Buy (unchanged) Price $74.20 Target (12 months) $83.50 (previously

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 16 July 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.655 Target (12 months) $0.95 (previously $0.98) Expected Return Capital growth

More information

Breaker Resources NL (BRB)

Breaker Resources NL (BRB) David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Speculative See key risks on Page 6. Speculative securities may not be suitable for retail clients 8 February 2019 Breaker NL (BRB) More

More information

Peet Bonds (PPCHA) A yield uplift from fixed rate senior debt

Peet Bonds (PPCHA) A yield uplift from fixed rate senior debt 4 May 2016 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 (PPCHA) Authorisation TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code Peet PPCHA Face value $100 Estimated

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 5 September 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.515 Target (12 months) $0.90 (previously $0.95) Expected Return Capital

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 19 April 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.76 Target (12 months) $0.98 (previously $1.00) Expected Return Capital growth

More information

Osprey Medical (OSP)

Osprey Medical (OSP) 18 October 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Osprey Medical (OSP) Harvey and Irma Curtail Growth Speculative See key risks on Page 5 and Biotechnology Risk Warning

More information

Galaxy Resources Ltd (GXY)

Galaxy Resources Ltd (GXY) Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Recommendation Buy (unchanged) Price $1.835 Valuation $3.35 (unchanged) -------------- Risk Speculative Expected Return Capital

More information

Mesoblast (MSB) GVHD granted Fast Track, should benefit ongoing negotiations with Mallinckrodt

Mesoblast (MSB) GVHD granted Fast Track, should benefit ongoing negotiations with Mallinckrodt 7 March 2017 Analyst Tanushree Jain 612 8224 2849 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $1.90 Valuation $3.22 (previously $3.17) Risk Speculative GICS Sector Pharmaceuticals

More information

National Australia Bank (NAB)

National Australia Bank (NAB) 29 March 2016 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $25.62 Target (12 months) $29.50 (unchanged) Expected Return Capital growth 15.1%

More information

7.0% fully franked yield (expected 10.0% gross): Fixed until Nov 2018 reset date

7.0% fully franked yield (expected 10.0% gross): Fixed until Nov 2018 reset date 6 July 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 William Spraggett 613 9235 1733 Whitefield Resettable Preference Shares (WHFPB) Authorisation John Gleeson 612 9255 7220

More information

Talisman Mining Ltd (TLM)

Talisman Mining Ltd (TLM) Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.41 Valuation $0.88 (previously $1.00) Risk Speculative Expected Return Capital growth

More information

FY18 - Half Year Investor Presentation 22 February 2018

FY18 - Half Year Investor Presentation 22 February 2018 Who are we? FY18 - Half Year Investor Presentation 22 February 2018 Jonathan Rubinsztein CEO Richard Leon CFO Disclaimer Forward looking statements: All statements other than statements of historical fact

More information

Galaxy Resources Ltd (GXY)

Galaxy Resources Ltd (GXY) 27 March 2018 Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Galaxy Resources Ltd (GXY) Mt Cattlin doing what it is meant to Recommendation Buy Price $3.16 Price Target $4.75

More information

Premier Investments (PMV)

Premier Investments (PMV) 4 April 2017 Analyst Sam Haddad 612 8224 2819 Authorisation TS Lim 612 8224 2810 Premier Investments (PMV) The Myers touch Recommendation Buy (unchanged) Price $14.20 Target (12 months) $17.65 (previously

More information

Fortescue Metals Group (FMG)

Fortescue Metals Group (FMG) 30 October 2015 Analyst David Coates 612 8224 2887 Authorisation John Hester 612 8224 2871 Recommendation Buy (Hold) Price $2.09 Target (12 months) $2.40 (unchanged) Expected Return Capital growth 14.8%

More information

Westgold Resources (WGX)

Westgold Resources (WGX) 7 February 2017 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $2.25 Target (12 months) $2.60 Expected Return Capital growth 15.6% Dividend

More information

Breaker Resources NL (BRB)

Breaker Resources NL (BRB) Analyst David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Recommendation Buy (unchanged) Price $0.315 Valuation $0.96 (previously $1.30) Risk Speculative GICS Sector Materials Expected

More information

St George Mining Ltd (SGQ)

St George Mining Ltd (SGQ) Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Recommendation Buy (unchanged) Price $0.225 Valuation $0.30 (previously $0.26) Risk Speculative Expected Return Capital growth

More information

Crowd Mobile (CM8) A Strong FY17 Result. 24 March Bell Potter Small Cap Team

Crowd Mobile (CM8) A Strong FY17 Result. 24 March Bell Potter Small Cap Team 24 March 2017 Crowd Mobile (CM8) A Strong FY17 Result 1. Crowd Mobile (CM8) delivered a strong set of FY17 results exceeding our revenue expectation by 3.3%, driven by an acceleration in fourth quarter

More information

Crowd Mobile Ltd. Track Deal Drives Valuation Upgrade BUY. Valuation $0.63

Crowd Mobile Ltd. Track Deal Drives Valuation Upgrade BUY. Valuation $0.63 Crowd Mobile Ltd Price: $0.19 Track Deal Drives Valuation Upgrade Overview: Crowd Mobile Limited ( Crowd Mobile, the Company ) is an Australian technology Company focused on mobile software and services.

More information

For personal use only

For personal use only Adacel Technologies Limited ABN 15 079 672 281 Suite 1, 342 South Road Hampton East, Victoria 3188 Australia T. +61 3 8530 7777 F. +61 3 9555 0068 www.adacel.com Adacel Technologies Limited (ASX: ADA)

More information

Pioneer Credit (PNC)

Pioneer Credit (PNC) 23 June 2014 Analyst Sam Byrnes 612 8224 2886 Authorisation Chris Savage 612 8224 2835 Pioneer Credit (PNC) Helping not chasing Recommendation Buy (Initiation) Price $1.55 Target (12 months) $1.80 Expected

More information

Value at the top end. Figure 1: Trading margins on debt and equity securities

Value at the top end. Figure 1: Trading margins on debt and equity securities 17 February 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation Steve Goldberg 612 8224 2809 Westpac Convertible Preference Shares (WBCPC) Fixed Interest Issue overview

More information

UBS Investment Research Brambles Limited

UBS Investment Research Brambles Limited UBS Investment Research Brambles Limited FY12 result: strong revenue momentum Result highlights strong revenue momentum Brambles FY12 result was slightly ahead of expectations, revealing 11% underlying

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 1 November 2016 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $1.38 Target (12 months) $2.10 (unchanged) Expected Return Capital growth

More information

Strike Energy Ltd (STX)

Strike Energy Ltd (STX) Analyst Peter Arden 613 9235 1833 Authorisation Stuart Howe 613 9235 1782 Recommendation Buy (unchanged) Price $0.115 Valuation $0.26 (previously $0.23) Risk Speculative Expected Return Capital growth

More information

BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS

BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS BUY 0.11 0.39 0.69 SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS CONTENTS Competitors Products Sales channels Pricing Model INVESTMENT THESIS COMPANY OVERVIEW INDUSTRY OVERVIEW COMPETITORS BOARD

More information

INDEPTH RESEARCH NOTE REA Group Ltd Neutral

INDEPTH RESEARCH NOTE REA Group Ltd Neutral 1 INDEPTH RESEARCH NOTE REA Group Ltd Neutral Price: A$72.97 Price Target: A$74.80 ASX: REA 12 February 2018 REA s first half FY18 (1H18) result was underpinned by strong growth in the Australian business

More information

MNF Group Limited (MNF)

MNF Group Limited (MNF) MNF Group Limited (MNF) 16 February 2018 Outperform 1H18 Results: Excessive Sell-off Presents Buying Opportunity $5.14 Chris Reindler creindler@taylorcollison.com.au +61 2 9210 1335 Summary (AUD) Market

More information

AMINO TECHNOLOGIES TECHNOLOGY HARDWARE AND EQUIPMENT

AMINO TECHNOLOGIES TECHNOLOGY HARDWARE AND EQUIPMENT AMINO TECHNOLOGIES TECHNOLOGY HARDWARE AND EQUIPMENT AMO.L 187.5p Market Cap: 134.7m SHARE PRICE (p) 240 190 140 90 Jul-16 12m high/low Source: LSE Data KEY INFORMATION Enterprise value Index/market 128.5m

More information

Regional Express Holdings Ltd REX

Regional Express Holdings Ltd REX 20 February 2006 REX $1.15 Analyst Ken Fleming (613) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (613) 6224 9899 Fully diluted shares on issue 115.0M Market cap A$132.3M Performance & Valuation Last

More information

Macquarie Group Capital Notes 2 (MQGPB) * MANDATORY CONVERSION IS SUBJECT TO SATISFYING THE MANDATORY CONVERSION CONDITIONS

Macquarie Group Capital Notes 2 (MQGPB) * MANDATORY CONVERSION IS SUBJECT TO SATISFYING THE MANDATORY CONVERSION CONDITIONS 23 November 2015 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation Macquarie Group Capital Notes 2 (MQGPB) TS Lim 612 8224 2810 Fixed Interest Issue overview Issuer Issue

More information

Consolidated Operations Group (COG)

Consolidated Operations Group (COG) Consolidated Operations Group (COG) 10 April 2018 Outperform Upgrade to OUTPERFORM - Inflection point nearing $0.10 Jason Palmer jpalmer@taylorcollison.com.au +618 8217 3965 Summary (AUD) Market Capitalisation

More information

Paragon Care (PGC) Big Boxes, Big Opportunity. Capitalising on the burgeoning healthcare sector. Price leadership through quality

Paragon Care (PGC) Big Boxes, Big Opportunity. Capitalising on the burgeoning healthcare sector. Price leadership through quality 26 September 2014 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Paragon Care (PGC) Big Boxes, Big Opportunity Recommendation Buy (Initiation) Price $0.33 Target (12 months) $0.38

More information

Aspire Mining Ltd (AKM)

Aspire Mining Ltd (AKM) 4 June 2012 Analyst Stuart Howe 613 9235 1782 Fred Truong 613 9235 1629 Authorisation Jonathan Snape 613 9235 1601 Aspire Mining Ltd (AKM) Ovoot PFS released Recommendation Buy (unchanged) Price $0.13

More information

For personal use only. Appen Limited. Global Leader in Language Technology Solutions. FY2014 Results Presentation

For personal use only. Appen Limited. Global Leader in Language Technology Solutions. FY2014 Results Presentation Appen Limited Global Leader in Language Technology Solutions FY2014 Results Presentation Agenda Topic: Introduction to Appen Financial Performance Growth and Outlook People and Leadership Speaker: Chris

More information

ONEVIEW HEALTHCARE PLC

ONEVIEW HEALTHCARE PLC ONEVIEW HEALTHCARE PLC BUY 2017 Result Green Shoots Emerging Health Care Equipment & Services / Health Care Technology 28 February 2018 COMPANY UPDATE Ticker ONE Stock Price $1.900 Target Price $3.04 Forecast

More information

Chinasoft International (0354 HK)

Chinasoft International (0354 HK) Equity Research Tech, Media & Telecom 11 Jun 2014 Chinasoft International (0354 HK) SaaS initiative in cloud business Advancing in SaaS cloud with government and corporates demand: Following exclusive

More information

Resetting expectations

Resetting expectations Company update 13 May 2016 TPI ENTERPRISES (TPE) Resetting expectations We retain a BUY rating with a revised 12-month price target of $3.21 p/sh. We assess market conditions to imply a more gradual ramp

More information

Appen Limited (APX-AU) 29 August 2017

Appen Limited (APX-AU) 29 August 2017 Appen Limited (APX-AU) 29 August 2017 Pricing in another Upgrade Marketperform Adam Dellaverde adamd@taylorcollison.com.au +618 8217 3923 +6403 013 032 Summary Market capitalisation ($m) $438.7 Share price

More information

Ride the recovery. Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call

Ride the recovery. Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call 17 May 2016 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code BELL POTTER SECURITIES LIMITED ACN

More information

FY18 Results Presentation Bravura Solutions Limited. 28 August 2018

FY18 Results Presentation Bravura Solutions Limited. 28 August 2018 FY18 Results Presentation Bravura Solutions Limited 28 August 2018 Important notice and disclaimer The information contained in this document (including this notice) and discussed at this presentation

More information

Insurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates

Insurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates 11 May 2018 RECOMMENDATIONS AUB Group (AUB) Rating HOLD Risk Low Price Target $14.50 Share Price $14.17 Steadfast Group (SDF) Rating HOLD Risk Low Price Target $2.80 Share Price $2.88 RESEARCH ANALYST

More information

Figure 1: ASX listed debt redemptions Figure 2: Trading margins on debt and equity securities

Figure 1: ASX listed debt redemptions Figure 2: Trading margins on debt and equity securities 8 February 2017 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation (NABPE) TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code NAB NABPE Face value $100

More information

COMPUMEDICS LTD HOLD. CMP Downgrades FY17 Guidance COMPANY UPDATE EVENT KEY TAKE-AWAYS INVESTMENT VIEW

COMPUMEDICS LTD HOLD. CMP Downgrades FY17 Guidance COMPANY UPDATE EVENT KEY TAKE-AWAYS INVESTMENT VIEW COMPUMEDICS LTD HOLD CMP Downgrades FY17 Guidance Health Care Equipment & Services / Health Care Equipment 7 July 2017 COMPANY UPDATE Ticker CMP Stock Price $0.560 Target Price $0.530 Forecast Capital

More information

Mesoblast (MSB) Major CHF catalyst next week, Time to get on board

Mesoblast (MSB) Major CHF catalyst next week, Time to get on board 9 November 2018 Analyst Tanushree Jain 612 8224 2849 Authorisation John Hester 612 8224 2871 Recommendation Buy (unchanged) Price $2.18 Valuation $4.06 (previously $3.95) Risk Speculative GICS Sector Pharmaceuticals

More information

For personal use only

For personal use only 22 August 2018 Company Announcements Office Australian Securities Exchange Limited 20 Bridge Street SYDNEY NSW 2000 By electronic lodgment Total Pages: 6 (including covering letter) Dear Sir / Madam APPENDIX

More information

Cash Converters Intl.

Cash Converters Intl. MICROCAP COMPANY RESEARCH Cash Converters Intl. 22 nd November 2012 GICS: Diversified Financials Consumer Finance 1Q13 Trading Update RECENT NEW S Cash Converters [ASX:CCV] recently provided a trading

More information

Figure 1: Bell Potter fair value assessment. 2.40%: July 2018 Fixed Rate Senior Bond (OTC yield 6.00%)

Figure 1: Bell Potter fair value assessment. 2.40%: July 2018 Fixed Rate Senior Bond (OTC yield 6.00%) 13 August 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation John Gleeson 612 9255 7220 Fixed Interest Issue overview Issuer Issue ASX code Crown CWNHA Face value $100

More information

Full Year Results Briefing 27 August 2015

Full Year Results Briefing 27 August 2015 Full Year Results Briefing 27 August 2015 David Gyngell CEO Simon Kelly COO/CFO Amanda Laing Commercial Director and Group General Counsel Alex Parsons MD, Nine Digital Peter Wiltshire Group Sales Director

More information

Half-year results 31 December GBST Holdings Limited (ASX: GBT)

Half-year results 31 December GBST Holdings Limited (ASX: GBT) Half-year results 31 December 2017 GBST Holdings Limited (ASX: GBT) H1 FY2018 Financial Performance Results for the half-year ($ millions) 1H FY18 2H FY17 1H FY17 REVENUE AND OTHER INCOME 42.7 42.6 45.4

More information

An Integrated Financial Services Company

An Integrated Financial Services Company An Integrated Financial Services Company Investor Presentation 22 November 2016 Disclaimer This document has been prepared by Sequoia Financial Group Limited, ACN 091 744 884 ( Company, we or us ). Information

More information

Noni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts

Noni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts Date 09 January 2018 Theme Company Update Company Noni B (NBL) BUY: FY18e EBITDA +12.8% NBL provided a positive 1H18 trading update today, advising LFL sales growth of 3.0% (1.5% in 1H17) and EBITDA of

More information

INVESTOR UPDATE OCTOBER 2016

INVESTOR UPDATE OCTOBER 2016 INVESTOR UPDATE OCTOBER 2016 IMPORTANT NOTE This information was prepared by Perpetual Investment Management Limited (PIML) ABN 18 000 866 535, AFSL 234426 and issued by Perpetual Trustee Company Limited

More information

Infomedia Ltd and controlled entities

Infomedia Ltd and controlled entities Appendix 4D 1 Infomedia Ltd and controlled entities Appendix 4D (rule 4.3A) Preliminary final report for the half year ended 31 December 2017 Results for announcement to the market (All comparisons to

More information

Adacel FY2018 H1 PBT $4.8 million, 15% above pcp, strong H2 outlook. FY2018 H1 PBT $4.8 million, approximately 15% above prior corresponding period

Adacel FY2018 H1 PBT $4.8 million, 15% above pcp, strong H2 outlook. FY2018 H1 PBT $4.8 million, approximately 15% above prior corresponding period Adacel Technologies Limited (ASX: ADA) Adacel Technologies Limited ABN 15 079 672 281 Suite 1, 342 South Road Hampton East, Victoria 3188 Australia T. +61 3 8530 7777 F. +61 3 9555 0068 W. www.adacel.com

More information

Family Zone Cyber Safety Limited (FZO) Company Update. Investment Summary. Investment Highlights. Investment Recommendation

Family Zone Cyber Safety Limited (FZO) Company Update. Investment Summary. Investment Highlights. Investment Recommendation BW EQUITIES RESEARCH 14 March 2017 Family Zone Cyber Safety Limited (FZO) Company Update BUY Rating: Target Price 1 : $0.46 Projected Return: 109% 1 12 month target Company Statistics Share Price (A$)

More information

EAST ASIA SECURITIES COMPANY LIMITED 9/F, 10 Des Voeux Road Central, Hong Kong. Dealing: Research: Facsimile:

EAST ASIA SECURITIES COMPANY LIMITED 9/F, 10 Des Voeux Road Central, Hong Kong. Dealing: Research: Facsimile: 9/F, 10 Des Voeux Road Central, Hong Kong. Dealing: 3608 8000 Research: 3608 8097 Facsimile: 3608 6132 HONG KONG RESEARCH Analyst: Vincent Leung 8 th August 2007. STANDARD CHARTERED PLC ( 渣打集團 ) Sector

More information

TBF SMALL CAP VALUE GROWTH FUND

TBF SMALL CAP VALUE GROWTH FUND TBF SMALL CAP VALUE GROWTH FUND AUGUST2014 Investment Manager TBF Investment Management Level 26, 44 Market St Sydney 2000 T. 02 9089 8854 E. info@tbfinvest.com.au www.tbfinvest.com.au www.facebook.com/theboatfund

More information

Full year results 30 June 2018.

Full year results 30 June 2018. CORPORATE TRAVEL MANAGEMENT Full year results 30 June 2018. Presented by: Jamie Pherous, Founder & Managing Director Date: 22 nd August, 2018 PAGE 2 Disclaimer The information in this presentation does

More information

For personal use only

For personal use only Results Presentation First Half Financial Results 31 December 2018 www.pscgroup.com.au Highlights 1 50 Revenue ($m) Revenue of $40.8m up 42% on 1HFY18 ($28.8m) Underlying EBITDA of $3.1m up 46.1% on 1HFY18

More information

For personal use only

For personal use only 20 th February 2018 ASX RELEASE Corporate Travel Management Reports Half Year Results On Track to Achieve Top End of FY18 Guidance 1H18 Results Highlights: Total Transaction Value (TTV) (unaudited) $2,258.5m

More information

Company Report. TCL Comm (2618 HK) Strong FY15E ahead backed by solid product roadmap in smartphone/wearables/apps/cloud; Reiterate BUY BUY

Company Report. TCL Comm (2618 HK) Strong FY15E ahead backed by solid product roadmap in smartphone/wearables/apps/cloud; Reiterate BUY BUY Company Report China Merchants Securities (HK) Co.Ltd. Hong Kong Equity Research TCL Comm (2618 HK) Strong FY15E ahead backed by solid product roadmap in smartphone/wearables/apps/cloud; Reiterate BUY

More information

Integrated Research (IRI) SELL: Growth and cash impediments

Integrated Research (IRI) SELL: Growth and cash impediments Date 17 August 218 Theme Company Update Company Integrated Research (IRI) SELL: Growth and cash impediments Integrated Research (IR) had pre-released their FY18 results to market in July flagging flat

More information

Crude oil rebounds. ASX SPI Futures up 27 points

Crude oil rebounds. ASX SPI Futures up 27 points Crude oil rebounds ASX SPI Futures up 27 points Powered by wise-owl.com YESTERDAY IN THE INTERNATIONAL MARKETS Global Ticker Daily Change U.S. Stocks Advance as Crude Oil Rebounds U.S. stocks advanced,

More information

Kingsoft (3888 HK) Buy (maintained) Target price: HK$20.77

Kingsoft (3888 HK) Buy (maintained) Target price: HK$20.77 Equity Research Information Technology May 24, 216 Kingsoft (3888 HK) Buy (maintained) Target price: HK$2.77 Full-year earnings forecast trimmed as 1Q16 results miss; maintain Buy but lower target price

More information

For personal use only. FY16 Results Presentation

For personal use only. FY16 Results Presentation FY16 Results Presentation PAGE 1 Agenda 1. Highlights 2. FY16 Results Trading performance Balance sheet and cash flow Capital management 3. Business Update Our objectives The JB HI-FI model Store portfolio

More information

ASX: DDR FY16 Results Presentation. March 2017

ASX: DDR FY16 Results Presentation. March 2017 ASX: DDR FY16 Results Presentation March 2017 Corporate Headlines Capital Structure Share Price (24 Mar 2017) $2.17 Fully paid ordinary shares 160.0m Options 0.0m Market Capitalisation $347.2m Shareholders

More information

PRICE $1.30 Regional Express Holdings Ltd REX

PRICE $1.30 Regional Express Holdings Ltd REX 16 November 2006 PRICE $1.30 Regional Express Holdings Ltd REX Analyst Ken Fleming (03) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (03) 6224 9899 Fully diluted shares on issue 115M Market cap A$133M

More information

Interim FY 2015 results 6 months ended 31 December February 2015

Interim FY 2015 results 6 months ended 31 December February 2015 Interim FY 2015 results 31 December 2014 18 February 2015 Highlights Solid trading result for 1H FY2015; change in accounting policy for acquisition of healthcare practices First half result highlights

More information

Chief Executive Officer : John Croll Chief Financial Officer : James Orlando

Chief Executive Officer : John Croll Chief Financial Officer : James Orlando 23 AUGUST 2017 FY17 RESULTS Chief Executive Officer : John Croll Chief Financial Officer : James Orlando isentia.com AGENDA Overview of FY17 Results Strategic Focus FY17 Financial Performance Q&A John

More information

QV Equities Limited. Investor Update - 1 -

QV Equities Limited. Investor Update - 1 - QV Equities Limited Investor Update - 1 - March roadshow 2015 QV Equities Limited Intro & Business Update Managed by Investors Mutual Focused on Ex-20 stocks Listed 22 August 2014 Quality and experienced

More information

Full year results 2017.

Full year results 2017. CORPORATE TRAVEL MANAGEMENT Full year results 2017. Presented by: Jamie Pherous, Founder & Managing Director Date: 22 nd August 2017 PAGE 2 Disclaimer. The information in this presentation does not constitute

More information

ANNUAL GENERAL MEETING OCTOBER 2015

ANNUAL GENERAL MEETING OCTOBER 2015 ANNUAL GENERAL MEETING OCTOBER 2015 Cautionary Statement Cautionary statement on forward-looking statements: Statements in this news release that are not historical facts, including statements that (i)

More information

1H17 Results Presentation 9 February ASX ticker: PGC

1H17 Results Presentation 9 February ASX ticker: PGC 1H17 Results Presentation 9 February 2017 ASX ticker: PGC Highlights Record revenue and earnings growth with positive outlook for full year FY17 Revenue (1H16: $38.4m) $55.0m 43% Gross profit (1H16: $14.8m)

More information

rhipe Limited (ASX code RHP) FY16 Full Year Results Presentation & FY 2017 Outlook

rhipe Limited (ASX code RHP) FY16 Full Year Results Presentation & FY 2017 Outlook rhipe Limited (ASX code RHP) FY16 Full Year Results Presentation & FY 2017 Outlook Dominic O Hanlon, CEO & Managing Director Mike Hill, Executive Chairman 1 This presentation has been prepared by rhipe

More information

Inabox Group Limited (ASX:IAB)

Inabox Group Limited (ASX:IAB) Inabox Group Limited (ASX:IAB) AGM Presentation November 2016 A leading hosted IT and communications solution provider to Corporates, SME s and consumer brands across Australia. We invest in our people,

More information